Gordon Carl L
Compass Therapeutics, Inc. · Director
Gordon Carl L is listed in filings as Director at Compass Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to Compass Therapeutics, Inc. (CMPX), Keros Therapeutics, Inc. (KROS), and Terns Pharmaceuticals, Inc. (TERN). The current snapshot covers public activity from Jun 14, 2024 to Jan 5, 2026. Reported amounts are shown as $465.3K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $10M220.6k shares | SellAug 13, 2024 | $44.01 | $10.61 | |
| $1M29.4k shares | SellAug 13, 2024 | $44.01 | $10.61 | |
| $40k4k shares | SellJul 16, 2024 | $10.00 | $52.95 | |
| $6.2k623 shares | SellJul 16, 2024 | $10.00 | $52.95 | |
| $5.6k556 shares | SellJul 16, 2024 | $10.00 | $52.95 | |
| $394k39.4k shares | SellJul 15, 2024 | $10.00 | $52.95 | |
| $61k6.1k shares | SellJul 15, 2024 | $10.00 | $52.95 | |
| $54k5.4k shares | SellJul 15, 2024 | $10.00 | $52.95 |